(Q35468072)

English

Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

multicenter clinical trial

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

Wolfgang H. Oertel

7

object named as

Oertel WH

1 reference

Europe PubMed Central

8 August 2017

author name string

Pogarell O

1

1 reference

Europe PubMed Central

8 August 2017

Gasser T

2

1 reference

Europe PubMed Central

8 August 2017

van Hilten JJ

3

1 reference

Europe PubMed Central

8 August 2017

Spieker S

4

1 reference

Europe PubMed Central

8 August 2017

Pollentier S

5

1 reference

Europe PubMed Central

8 August 2017

Meier D

6

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

8 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

8 August 2017

72

1 reference

Europe PubMed Central

8 August 2017

6

1 reference

Europe PubMed Central

8 August 2017

713-720

1 reference

Europe PubMed Central

8 August 2017

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Assessing tremor severity with long-term tremor recordings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

27 July 2018

Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

26 September 2018

Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

26 September 2018

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

26 September 2018

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

26 September 2018

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1737934

26 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability, specificity and sensitivity of long-term tremor recordings

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tremors in Parkinson's disease: symptom analysis and rating

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/12023411

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.72.6.713

1 reference

https://api.fatcat.wiki/v0/release/rhdey5toyjedtfx7cqjag2xec4

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_rhdey5toyjedtfx7cqjag2xec4

1 reference

https://api.fatcat.wiki/v0/release/rhdey5toyjedtfx7cqjag2xec4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/rhdey5toyjedtfx7cqjag2xec4

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/rhdey5toyjedtfx7cqjag2xec4

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35468072&oldid=1801654243"